(CIM) Chimera Investment - Ratings and Ratios
Residential Loans, Mortgage-Backed Securities, Commercial Mortgage Loans
CIM EPS (Earnings per Share)
CIM Revenue
Description: CIM Chimera Investment
Chimera Investment Corporation is a mortgage real estate investment trust (REIT) that specializes in investing in a diverse portfolio of mortgage assets, including residential and commercial mortgage-backed securities, and other real estate-related securities. The companys investment strategy focuses on generating attractive risk-adjusted returns through a combination of interest income and potential capital appreciation.
As a REIT, Chimera is required to distribute at least 90% of its taxable income to shareholders in the form of dividends, making it an attractive investment opportunity for income-seeking investors. The companys investment portfolio is managed actively to optimize returns and minimize risk, with a focus on securities that offer a balance of yield and credit quality.
Chimeras investment portfolio includes a range of mortgage assets, such as residential mortgage loans, agency and non-agency residential mortgage-backed securities, and commercial mortgage-backed securities. The companys ability to invest in a broad range of securities allows it to diversify its portfolio and capitalize on opportunities in different segments of the mortgage market.
Based on the current technical and fundamental data, we can forecast that Chimera Investment Corporation is likely to continue its trend of stable dividend payments, given its REIT status and history of distributing a significant portion of its taxable income to shareholders. The companys current price of $13.88 is above its 50-day SMA of $13.52 and 200-day SMA of $13.66, indicating a positive trend. Additionally, the stocks P/E ratio of 8.82 and forward P/E ratio of 6.33 suggest that it may be undervalued relative to its earnings potential. With a market capitalization of $1.08 billion and a return on equity of 8.11%, Chimera Investment Corporation is well-positioned to continue delivering attractive returns to shareholders.
Using the available technical data, a potential trading strategy could be to buy CIM on a pullback to its 20-day SMA of $13.52, with a target price of $15.39, the 52-week high. The average true range (ATR) of 0.34, or 2.42%, suggests that the stock has a moderate level of volatility, making it a relatively stable investment opportunity. By combining technical and fundamental analysis, investors can make a more informed decision about investing in Chimera Investment Corporation.
CIM Stock Overview
Market Cap in USD | 1,107m |
Sector | Real Estate |
Industry | REIT - Mortgage |
GiC Sub-Industry | Mortgage REITs |
IPO / Inception | 2007-11-16 |
CIM Stock Ratings
Growth Rating | -33.7 |
Fundamental | 45.6 |
Dividend Rating | 33.1 |
Rel. Strength | -2.88 |
Analysts | 3.60 of 5 |
Fair Price Momentum | 14.18 USD |
Fair Price DCF | 19.49 USD |
CIM Dividends
Dividend Yield 12m | 11.03% |
Yield on Cost 5y | 9.86% |
Annual Growth 5y | -19.50% |
Payout Consistency | 78.8% |
Payout Ratio | 129.8% |
CIM Growth Ratios
Growth Correlation 3m | 63.6% |
Growth Correlation 12m | -35.7% |
Growth Correlation 5y | -71.5% |
CAGR 5y | -2.38% |
CAGR/Max DD 5y | -0.03 |
Sharpe Ratio 12m | -0.14 |
Alpha | -14.75 |
Beta | 0.612 |
Volatility | 27.99% |
Current Volume | 500.6k |
Average Volume 20d | 434.8k |
Stop Loss | 12.9 (-3.1%) |
As of August 08, 2025, the stock is trading at USD 13.31 with a total of 500,591 shares traded.
Over the past week, the price has changed by -0.45%, over one month by -5.67%, over three months by +13.82% and over the past year by +1.22%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Chimera Investment (NYSE:CIM) is currently (August 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 45.58 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CIM is around 14.18 USD . This means that CIM is currently overvalued and has a potential downside of 6.54%.
Chimera Investment has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold CIM.
- Strong Buy: 1
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, CIM Chimera Investment will be worth about 15.3 in August 2026. The stock is currently trading at 13.31. This means that the stock has a potential upside of +15.1%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 15.5 | 16.5% |
Analysts Target Price | 15.8 | 18.3% |
ValueRay Target Price | 15.3 | 15.1% |
CIM Fundamental Data Overview
CCE Cash And Equivalents = 253.3m USD (last quarter)
P/E Trailing = 9.053
P/E Forward = 6.3251
P/S = 3.3875
P/B = 0.4116
P/EG = -28.14
Beta = 1.863
Revenue TTM = 309.1m USD
EBIT TTM = 711.9m USD
EBITDA TTM = 534.4m USD
Long Term Debt = 10.40b USD (last quarter)
Short Term Debt = 3.37b USD (last quarter)
Net Debt = 10.14b USD (last quarter)
Debt = 13.77b USD (Short Term 3.37b + Long Term 10.40b)
Enterprise Value = 14.62b USD (Market Cap 1.11b + Debt 13.77b - CCE 253.3m)
Interest Coverage Ratio = 1.43 (Ebit TTM 711.9m / Interest Expense TTM 496.2m)
FCF Yield = 1.35% (FCF TTM 197.2m / Enterprise Value 14.62b)
FCF Margin = 63.80% (FCF TTM 197.2m / Revenue TTM 309.1m)
Net Margin = 69.21% (Net Income TTM 213.9m / Revenue TTM 309.1m)
Gross Margin = 90.44% ((Revenue TTM 309.1m - Cost of Revenue TTM 29.6m) / Revenue TTM)
[93m Tobins Q-Ratio = -2.09 (Enterprise Value 14.62b / Book Value Of Equity -6.99b)
[39m Interest Expense / Debt = 0.88% (Interest Expense 121.4m / Debt 13.77b)
Taxrate = 0.03% (Income Tax Expense 49.0k / Income Before Tax 176.1m, last fiscal year)
NOPAT = 711.7m (EBIT 711.9m × (1 – 0.03%))
Current Ratio = 0.10 (Total Current Assets 337.4m / Total Current Liabilities 3.53b)
Debt / Equity = 5.21 (Debt 13.77b / last Quarter total Stockholder Equity 2.64b)
Debt / EBITDA = 25.76 (Net Debt 10.14b / EBITDA 534.4m)
Debt / FCF = 69.80 (Debt 13.77b / FCF TTM 197.2m)
Total Stockholder Equity = 2.64b (last 4 quarters mean)
RoA = 1.62%
RoE = 8.11% (Net Income TTM 213.9m / Total Stockholder Equity 2.64b)
RoCE = 5.46% (Ebit 711.9m / Total Stockholder Equity 2.64b + Long Term Debt 10.40b)
RoIC = 5.51% (NOPAT 711.7m / Invested Capital 12.91b)
WACC = 2.02% ((Market Cap / EV) * CAPM 15.96%) + (Debt / EV) * Interest Expense on Debt * (1 - Taxrate)
Shares Correlation 5-Years: -80.0 | Cagr: -18.97%
Discount Rate = 15.96% (= CAPM)
Fair Price DCF = 19.49 (DCF Value 1.58b / Shares Outstanding 81.0m)
Revenue Correlation: 26.25 | Revenue CAGR: 51.66%
Revenue Growth Correlation: 31.50%
EPS Correlation: 55.55 | EPS CAGR: 70.33%
EPS Growth Correlation: 21.61%
Additional Sources for CIM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle